Fundraising Fox

Geno

Cocoa, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

TB
Todd BradyDirector
TM
Theo Melas-KyriaziDirector
BF
Brent FurseExecutive Officer, Director
VP
Vinzenz PloererDirector
DH
David H. Fine, Ph.D.Executive Officer, Director
TS
Tod ShultzExecutive Officer
DS
Dan Salazar, Ph.D.Director
AL
Anthony LoumidisExecutive Officer
PA
Paul AntinoriExecutive Officer
TS
T. Scott Johnson, M.D.Director

Investors · 1

Reported raises · per SEC filings

Form D private placements
$27.3MraisedDec 2021 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Todd BradyDirector
  • Daniel SalazarDirector
  • Thiago TavaresDirector
  • Shasha ZouExecutive Officer
  • Eric BednarskiDirector
  • Brent V. FurseExecutive Officer, Director
  • Roberto CohenExecutive Officer
Offering amount
$99.5M
Amount sold
$27.3M
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$29.9MraisedSep 2017 · 31 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Todd BradyDirector
  • Theo Melas-KyriaziDirector
  • Brent FurseExecutive Officer, Director
  • Vinzenz PloererDirector
  • David H. Fine, Ph.D.Executive Officer, Director
  • Tod ShultzExecutive Officer
  • Dan Salazar, Ph.D.Director
  • Anthony LoumidisExecutive Officer
  • Paul AntinoriExecutive Officer
  • T. Scott Johnson, M.D.Director
Offering amount
$35.1M
Amount sold
$29.9M
First sale
Sep 2017
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.